ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,185.37
-1.13%
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs Yen
155.5955
-0.05%
Brent Oil
83.76
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. AMEX
  6. Nighthawk Biosciences Inc (NHWK)

  7. Nighthawk Biosciences Inc (NHWK) ニュース

NHWK

Nighthawk Biosciences (NHWK)

Nighthawk Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:NHWK
日付受信時刻ニュースソース見出しコード企業名
2024/05/0405 : 00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NHWKNighthawk Biosciences Inc
2024/05/0320 : 18Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:NHWKNighthawk Biosciences Inc
2024/05/0221 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/04/3021 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/04/2921 : 10Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/04/2306 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/04/0205 : 52Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:NHWKNighthawk Biosciences Inc
2024/03/1921 : 30GlobeNewswire Inc.Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major UniversityAMEX:NHWKNighthawk Biosciences Inc
2024/03/1421 : 30GlobeNewswire Inc.Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-ConsortiumAMEX:NHWKNighthawk Biosciences Inc
2024/03/1319 : 17Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]AMEX:NHWKNighthawk Biosciences Inc
2024/03/1319 : 01Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/03/1306 : 00GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Closing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
2024/03/0814 : 20GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Pricing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
2024/03/0806 : 18GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Proposed Public Offering of Common StockAMEX:NHWKNighthawk Biosciences Inc
2024/03/0722 : 30GlobeNewswire Inc.Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023AMEX:NHWKNighthawk Biosciences Inc
2024/02/0623 : 34Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/02/0622 : 00GlobeNewswire Inc.NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open TodayAMEX:NHWKNighthawk Biosciences Inc
2024/02/0122 : 00GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating OfficerAMEX:NHWKNighthawk Biosciences Inc
2024/01/3022 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/01/3022 : 00GlobeNewswire Inc.NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing NoteAMEX:NHWKNighthawk Biosciences Inc
2024/01/2706 : 30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/01/2522 : 30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical ProgramAMEX:NHWKNighthawk Biosciences Inc
2024/01/2222 : 00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/01/1622 : 30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/01/1622 : 30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New ClientAMEX:NHWKNighthawk Biosciences Inc
2024/01/1206 : 59Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/01/0822 : 30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
2024/01/0822 : 30GlobeNewswire Inc.NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMOAMEX:NHWKNighthawk Biosciences Inc
2024/01/0322 : 30GlobeNewswire Inc.NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National UniversityAMEX:NHWKNighthawk Biosciences Inc
2023/12/2806 : 57Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
 Showing the most relevant articles for your search:AMEX:NHWK

最近閲覧した銘柄

NASDAQ
SBLKZ
Star Bulk Carriers
NYSE
WFC-A
Wells Fargo
TG
ZYR1
Cornish Metals
BIT
F34594
Vontobel Financial Produ...
LSE
JRCD
Jpm Chna Etf D
AMEX
DUSL
Direxion Daily Industria...
BIT
P1K2X7
BNP Paribas Issuance
BIT
P1KFN2
BNP Paribas Issuance
KUCN
OOKIUSDT
Ooki Token
BIT
P1K3L0
BNP Paribas Issuance
BOV
LRENE138
LRENE138 Ex:13,72
BIT
P1ID66
BNP Paribas Issuance
BIT
P10A10
Bnp Paribas Issuance
BIT
P1O5B2
BNP Paribas Issuance
TSXV
HEL
BIT
P1R3W0
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有